Literature DB >> 20975655

Pharmacotherapy: Xanthine oxidase inhibition for relief of angina pectoris.

Ranil de Silva, Kim M Fox.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20975655     DOI: 10.1038/nrcardio.2010.143

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN: 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  10 in total

1.  Long-term compliance with beta-blockers, angiotensin-converting enzyme inhibitors, and statins after acute myocardial infarction.

Authors:  Gunnar H Gislason; Jeppe N Rasmussen; Steen Z Abildstrøm; Niels Gadsbøll; Pernille Buch; Jens Friberg; Søren Rasmussen; Lars Køber; Steen Stender; Mette Madsen; Christian Torp-Pedersen
Journal:  Eur Heart J       Date:  2006-01-06       Impact factor: 29.983

2.  Executive summary: heart disease and stroke statistics--2010 update: a report from the American Heart Association.

Authors:  Donald Lloyd-Jones; Robert J Adams; Todd M Brown; Mercedes Carnethon; Shifan Dai; Giovanni De Simone; T Bruce Ferguson; Earl Ford; Karen Furie; Cathleen Gillespie; Alan Go; Kurt Greenlund; Nancy Haase; Susan Hailpern; P Michael Ho; Virginia Howard; Brett Kissela; Steven Kittner; Daniel Lackland; Lynda Lisabeth; Ariane Marelli; Mary M McDermott; James Meigs; Dariush Mozaffarian; Michael Mussolino; Graham Nichol; Véronique L Roger; Wayne Rosamond; Ralph Sacco; Paul Sorlie; Randall Stafford; Thomas Thom; Sylvia Wasserthiel-Smoller; Nathan D Wong; Judith Wylie-Rosett
Journal:  Circulation       Date:  2010-02-23       Impact factor: 29.690

3.  Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease.

Authors:  P W Serruys; F Unger; J E Sousa; A Jatene; H J Bonnier; J P Schönberger; N Buller; R Bonser; M J van den Brand; L A van Herwerden; M A Morel; B A van Hout
Journal:  N Engl J Med       Date:  2001-04-12       Impact factor: 91.245

4.  Allopurinol reduces B-type natriuretic peptide concentrations and haemoglobin but does not alter exercise capacity in chronic heart failure.

Authors:  A D Gavin; A D Struthers
Journal:  Heart       Date:  2005-06       Impact factor: 5.994

Review 5.  Trimetazidine for stable angina.

Authors:  A Ciapponi; R Pizarro; J Harrison
Journal:  Cochrane Database Syst Rev       Date:  2005-10-19

6.  Effect of high-dose allopurinol on exercise in patients with chronic stable angina: a randomised, placebo controlled crossover trial.

Authors:  Awsan Noman; Donald S C Ang; Simon Ogston; Chim C Lang; Allan D Struthers
Journal:  Lancet       Date:  2010-06-09       Impact factor: 79.321

7.  Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.

Authors:  Bernard R Chaitman; Carl J Pepine; John O Parker; Jaroslav Skopal; Galina Chumakova; Jerzy Kuch; Whedy Wang; Sandra L Skettino; Andrew A Wolff
Journal:  JAMA       Date:  2004-01-21       Impact factor: 56.272

8.  Effect of PCI on quality of life in patients with stable coronary disease.

Authors:  William S Weintraub; John A Spertus; Paul Kolm; David J Maron; Zefeng Zhang; Claudine Jurkovitz; Wei Zhang; Pamela M Hartigan; Cheryl Lewis; Emir Veledar; Jim Bowen; Sandra B Dunbar; Christi Deaton; Stanley Kaufman; Robert A O'Rourke; Ron Goeree; Paul G Barnett; Koon K Teo; William E Boden; G B J Mancini
Journal:  N Engl J Med       Date:  2008-08-14       Impact factor: 91.245

9.  Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology.

Authors:  Kim Fox; Maria Angeles Alonso Garcia; Diego Ardissino; Pawel Buszman; Paolo G Camici; Filippo Crea; Caroline Daly; Guy De Backer; Paul Hjemdahl; José Lopez-Sendon; Jean Marco; João Morais; John Pepper; Udo Sechtem; Maarten Simoons; Kristian Thygesen; Silvia G Priori; Jean-Jacques Blanc; Andrzej Budaj; John Camm; Veronica Dean; Jaap Deckers; Kenneth Dickstein; John Lekakis; Keith McGregor; Marco Metra; João Morais; Ady Osterspey; Juan Tamargo; José L Zamorano
Journal:  Eur Heart J       Date:  2006-05-30       Impact factor: 29.983

10.  Efficacy of the I(f) current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy: a 4-month, randomized, placebo-controlled trial.

Authors:  Jean-Claude Tardif; Piotr Ponikowski; Thomas Kahan
Journal:  Eur Heart J       Date:  2009-01-09       Impact factor: 29.983

  10 in total
  2 in total

1.  Angina treatments and prevention of cardiac events: an appraisal of the evidence.

Authors:  David E Winchester; Carl J Pepine
Journal:  Eur Heart J Suppl       Date:  2015-12-16       Impact factor: 1.803

Review 2.  The Role of Ivabradine in the Management of Angina Pectoris.

Authors:  Alessandra Giavarini; Ranil de Silva
Journal:  Cardiovasc Drugs Ther       Date:  2016-08       Impact factor: 3.727

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.